Interacting Drugs |
Ketoconazole (systemic) vs Tamoxifen |
Security Level |
|
Mechanism |
Tamoxifen: CYP2D6 Inhibitors (Moderate) may decrease the metabolism of Tamoxifen. Specifically, CYP2D6 inhibitors may decrease the formation of highly potent active metabolites. |
Management |
Consider alternatives with less of an inhibitory effect on CYP2D6 activity when possible. |
Ketoconazole (systemic) vs Tamoxifen
Post Review about Ketoconazole (systemic) vs Tamoxifen Click here to cancel reply.
Other Interactions of Ketoconazole (systemic)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.